These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10574939)

  • 1. Multiple charged and aromatic residues in CCR5 amino-terminal domain are involved in high affinity binding of both chemokines and HIV-1 Env protein.
    Blanpain C; Doranz BJ; Vakili J; Rucker J; Govaerts C; Baik SS; Lorthioir O; Migeotte I; Libert F; Baleux F; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Dec; 274(49):34719-27. PubMed ID: 10574939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function.
    Lee B; Sharron M; Blanpain C; Doranz BJ; Vakili J; Setoh P; Berg E; Liu G; Guy HR; Durell SR; Parmentier M; Chang CN; Price K; Tsang M; Doms RW
    J Biol Chem; 1999 Apr; 274(14):9617-26. PubMed ID: 10092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    Blanpain C; Doranz BJ; Bondue A; Govaerts C; De Leener A; Vassart G; Doms RW; Proudfoot A; Parmentier M
    J Biol Chem; 2003 Feb; 278(7):5179-87. PubMed ID: 12466283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
    Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
    Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding.
    Wu L; LaRosa G; Kassam N; Gordon CJ; Heath H; Ruffing N; Chen H; Humblias J; Samson M; Parmentier M; Moore JP; Mackay CR
    J Exp Med; 1997 Oct; 186(8):1373-81. PubMed ID: 9334377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
    Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
    J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1.
    Siciliano SJ; Kuhmann SE; Weng Y; Madani N; Springer MS; Lineberger JE; Danzeisen R; Miller MD; Kavanaugh MP; DeMartino JA; Kabat D
    J Biol Chem; 1999 Jan; 274(4):1905-13. PubMed ID: 9890944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry.
    Dragic T; Trkola A; Lin SW; Nagashima KA; Kajumo F; Zhao L; Olson WC; Wu L; Mackay CR; Allaway GP; Sakmar TP; Moore JP; Maddon PJ
    J Virol; 1998 Jan; 72(1):279-85. PubMed ID: 9420225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Bondue A; Jao SC; Blanpain C; Parmentier M; LiWang PJ
    Biochemistry; 2002 Nov; 41(46):13548-55. PubMed ID: 12427015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.
    Kuhmann SE; Platt EJ; Kozak SL; Kabat D
    J Virol; 1997 Nov; 71(11):8642-56. PubMed ID: 9343222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
    Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
    J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.
    Blanpain C; Lee B; Vakili J; Doranz BJ; Govaerts C; Migeotte I; Sharron M; Dupriez V; Vassart G; Doms RW; Parmentier M
    J Biol Chem; 1999 Jul; 274(27):18902-8. PubMed ID: 10383387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.
    Rabut GE; Konner JA; Kajumo F; Moore JP; Dragic T
    J Virol; 1998 Apr; 72(4):3464-8. PubMed ID: 9525683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
    Blanpain C; Lee B; Tackoen M; Puffer B; Boom A; Libert F; Sharron M; Wittamer V; Vassart G; Doms RW; Parmentier M
    Blood; 2000 Sep; 96(5):1638-45. PubMed ID: 10961858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.
    Govaerts C; Bondue A; Springael JY; Olivella M; Deupi X; Le Poul E; Wodak SJ; Parmentier M; Pardo L; Blanpain C
    J Biol Chem; 2003 Jan; 278(3):1892-903. PubMed ID: 12411445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
    Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
    J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.
    Königs C; Rowley MJ; Thompson P; Myers MA; Scealy M; Davies JM; Wu L; Dietrich U; Mackay CR; Mackay IR
    Eur J Immunol; 2000 Apr; 30(4):1162-71. PubMed ID: 10760806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.